GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (FRA:BBZA) » Definitions » Asset Turnover

BB Biotech AG (FRA:BBZA) Asset Turnover : 0.04 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is BB Biotech AG Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. BB Biotech AG's Revenue for the three months ended in Dec. 2023 was €117.88 Mil. BB Biotech AG's Total Assets for the quarter that ended in Dec. 2023 was €2,710.94 Mil. Therefore, BB Biotech AG's Asset Turnover for the quarter that ended in Dec. 2023 was 0.04.

Asset Turnover is linked to ROE % through Du Pont Formula. BB Biotech AG's annualized ROE % for the quarter that ended in Dec. 2023 was 19.41%. It is also linked to ROA % through Du Pont Formula. BB Biotech AG's annualized ROA % for the quarter that ended in Dec. 2023 was 17.07%.


BB Biotech AG Asset Turnover Historical Data

The historical data trend for BB Biotech AG's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Asset Turnover Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.19 -0.11 -0.11 -0.07

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.09 - -0.02 0.04

Competitive Comparison of BB Biotech AG's Asset Turnover

For the Biotechnology subindustry, BB Biotech AG's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Asset Turnover distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Asset Turnover falls into.



BB Biotech AG Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

BB Biotech AG's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-211.613/( (3094.031+2796.335)/ 2 )
=-211.613/2945.183
=-0.07

BB Biotech AG's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=117.88/( (2625.538+2796.335)/ 2 )
=117.88/2710.9365
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


BB Biotech AG  (FRA:BBZA) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

BB Biotech AG's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=462.808/2384.799
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(462.808 / 471.52)*(471.52 / 2710.9365)*(2710.9365/ 2384.799)
=Net Margin %*Asset Turnover*Equity Multiplier
=98.15 %*0.1739*1.1368
=ROA %*Equity Multiplier
=17.07 %*1.1368
=19.41 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

BB Biotech AG's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=462.808/2710.9365
=(Net Income / Revenue)*(Revenue / Total Assets)
=(462.808 / 471.52)*(471.52 / 2710.9365)
=Net Margin %*Asset Turnover
=98.15 %*0.1739
=17.07 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


BB Biotech AG Asset Turnover Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (FRA:BBZA) Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (FRA:BBZA) Headlines

No Headlines